Leucogenics Company
The purpose of the Leucogenics is the research, development and marketing of immunosuppressive therapies and diagnoses. Leucogenics may acquire, manage and sell real estate as well as any business directly or indirectly related to the purpose of the Company. The company also participates in other, domestic or foreign companies of all kinds.
Investment Stage:
N/A
Funding Status:
Undisclosed
Investor Type:
N/A
Employee Number:
Undisclosed
Industry:
P3 Medicine
Number Of Exists:
N/A
Headquarters:
Basel, Basel-Stadt, Switzerland
Founded Date:
2009
Technology:
Precision Medicine